Recent Analyst Ratings and Insider Activity for $RDFN
Benchmark recently assigned a ‘Mixed’ rating for $RDFN, providing insight into its market outlook.
Analyst Ratings Overview
In the past few months, Wall Street analysts have evaluated $RDFN. Notably, one firm has issued a buy rating, while no sell ratings have been reported.
Recent analyst ratings include:
- Zelman issued an “Outperform” rating on March 5, 2025.
For ongoing updates on analyst ratings and price targets for $RDFN, please refer to Quiver Quantitative’s $RDFN forecast page.
Insider Trading Activity at $RDFN
Insiders have conducted six trades involving $RDFN’s stock over the last six months, all of which were sales—no purchases were made during this period.
Recent insider trading activity includes:
- BRIDGET FREY (Chief Technology Officer) sold 156,787 shares, totaling an estimated $1,567,870.
- CHRISTIAN JOHN TAUBMAN (Chief Growth Officer) sold 32,542 shares for an estimated $318,533.
- ANTHONY RAY KAPPUS (Chief Legal Officer) sold 30,606 shares for an estimated $202,980.
For detailed tracking of insider transactions, explore Quiver Quantitative’s insider trading dashboard.
Hedge Fund Activity Related to $RDFN
In the most recent quarter, 121 institutional investors increased their shares of $RDFN, while 179 reduced their holdings.
Significant recent hedge fund movements include:
- MAGNETAR FINANCIAL LLC added 4,234,616 shares (+inf%) for an estimated $39,000,813.
- MARSHALL WACE, LLP added 4,057,698 shares (+797.1%) for an estimated $37,371,398.
- UBS GROUP AG added 2,640,780 shares (+427.4%) for an estimated $24,321,583.
- AMERICAN CENTURY COMPANIES INC sold 2,624,029 shares (-100.0%) for an estimated $24,167,307.
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 2,400,000 shares (+inf%) for an estimated $22,104,000.
- ALPINE ASSOCIATES MANAGEMENT INC. added 1,319,215 shares (+inf%) for an estimated $12,149,970.
- TWO SIGMA ADVISERS, LP sold 1,309,400 shares (-51.9%) for an estimated $12,059,574.
To monitor hedge fund activities concerning $RDFN, visit Quiver Quantitative’s institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative’s disclaimers for more information.
This article was originally published on Quiver News; read the full story.
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.